Immunotech Biopharm Ltd is an innovative technology enterprise specializing in the research and development of immunotherapeutic drugs. It has been recognized as a national high-tech enterprise and has internationally advanced technology and rich research and development experience.
About us
News
GOOD NEWS | YONGTAI RUIKE HAS SUCCESSFULLY OBTAINED THE NATIONAL "HIGH-TECH ENTERPRISE" CERTIFICATION!
GOOD NEWS | YONGTAI RUIKE HAS SUCCESSFULLY OBTAINED THE NATIONAL "HIGH-TECH ENTERPRISE" CERTIFICATION!
Immunotech Biophara Ltd-B (06978. HK) and Corning Incorporated Jointly Expanding Product Commercialization Cooperation
Immunotech Biophara Ltd-B (06978. HK) and Corning Incorporated Jointly Expanding Product Commercialization Cooperation
HEAVYWEIGHT AWARD | IMMUNOTECH BIOPHARA LTD-B (06978. HK) WAS AWARDED THE "OUTSTANDING INNOVATION ENTERPRISE" IN BEIJING ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE IN 2023
HEAVYWEIGHT AWARD | IMMUNOTECH BIOPHARA LTD-B (06978. HK) WAS AWARDED THE "OUTSTANDING INNOVATION ENTERPRISE" IN BEIJING ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE IN 2023
Clinical Progress | Immunotech Biophara Ltd-B (06978. HK) aT19 Injection Successfully received an approval of Clinical Trial
Clinical Progress | Immunotech Biophara Ltd-B (06978. HK) aT19 Injection Successfully received an approval of Clinical Trial
Research
Patient
From November 2006 to April 2016, EAL® products have been used in clinical treatment of more than 4,000 patients in dozens of hospitals.
Recruitment
Address：8th Floor, Building 1, No. 1, Kangding Street, Beijing Economic and Technological Development Zone, Beijing
Resume delivery email：hr@eaal.net
Contact numbe：010-88400295
Website construction: China Enterprise Power京ICP备19008112号 PowerBy:300.cn Beijing
